-
Mashup Score: 1Ilana Schlam: Excited to kick off my first day at Dana-Farber’s Breast Oncology Center - OncoDaily - 3 day(s) ago
Ilana Schlam: Excited to kick off my first day at Dana-Farber’s Breast Oncology Center / cancer, Dana-Farber’s Breast Oncology Center, Ilana Schlam,
Source: oncodaily.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 3
Carmine Valenza: ICIs in patients with metastatic TN-IBC / cancer, Carmine Valenza, Dario Trapani, European Institute of Oncology, Giuseppe Curigliano, IEO,
Source: oncodaily.comCategories: General Medicine News, Hem/OncsTweet-
RT @OncoDailyIO: ICIs in patients with metastatic TN-IBC - @ValenzaCarmine @curijoey @darioT_ https://t.co/UjcUKrtEcb #Cancer #ImmuneOnc…
-
-
Mashup Score: 21
Triple-negative breast cancer (TNBC) is the most aggressive breast cancer subtype and has the highest rate of recurrence1. The predominant standard of care for advanced TNBC is systemic chemotherapy with or without immunotherapy; however, responses are typically short lived1,2. …
Source: pubmed.ncbi.nlm.nih.govCategories: General Medicine News, Hem/OncsTweet-
RT @DFCI_BreastOnc: New research📰: AKT and EZH2 inhibitors kill TNBCs by hijacking mechanisms of involution. 🔓https://t.co/h2vvmrEHtY ✍️@k…
-
-
Mashup Score: 1The 7th Annual B-PREP Patient Forum - Dana-Farber’s Breast Oncology Center - OncoDaily - 25 day(s) ago
The 7th Annual B-PREP Patient Forum – Dana-Farber’s Breast Oncology Center / Breast Cancer, breast cancer awareness, breast cancer awareness month, breast
Source: oncodaily.comCategories: General Medicine News, Hem/OncsTweet-
RT @oncodaily: The 7th Annual B-PREP Patient Forum - @DFCI_BreastOnc @TariKingMD @EMittendorfMD https://t.co/8rSswpybuW #Cancer #BSCM #Me…
-
-
Mashup Score: 1Paolo Tarantino: The largest HER2-low sub-analysis of a RCT led by Guilherme Nader-Marta - OncoDaily - 30 day(s) ago
Paolo Tarantino: The largest HER2-low sub-analysis of a RCT led by Guilherme Nader-Marta / Breast Cancer, Breast Cancer Research, cancer, Christian Singer,
Source: oncodaily.comCategories: General Medicine News, Hem/OncsTweet-
RT @oncodaily: The largest HER2-low sub-analysis of a RCT led by @GuiNaderMarta - @PTarantinoMD https://t.co/jjHHP9kyAc #BreastCancer #C…
-
-
Mashup Score: 11100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2024: Part 6 - OncoDaily - 1 month(s) ago
100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2024: Part 6 / 100 Influential Women in Oncology, cancer, Danielle
Source: oncodaily.comCategories: General Medicine News, Hem/OncsTweet-
RT @oncodaily: 100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2024: Part 6 https://t.co/lW0Ct8V0Mj T…
-
-
Mashup Score: 1The recipient of this year’s Susan E. Donelan Lecture is Faina Nakhlis - Dana-Farber IBC Program - OncoDaily - 1 month(s) ago
The recipient of this year’s Susan E. Donelan Lecture is Faina Nakhlis – Dana-Farber IBC Program / cancer, Dana-Farber IBC Program, Faina Nakhlis, OncoDaily,
Source: oncodaily.comCategories: General Medicine News, Hem/OncsTweet-
RT @oncodaily: The recipient of this year’s Susan E. Donelan Lecture is Faina Nakhlis - @IBC_DanaFarber https://t.co/lyMbnVCktL #Cancer…
-
-
Mashup Score: 2ESMO24 symposium on the management of oligoprogressive disease - Dana-Farber’s Breast Oncology Center - OncoDaily - 2 month(s) ago
ESMO24 symposium on the management of oligoprogressive disease – Dana-Farber’s Breast Oncology Center / cancer, Dana-Farber’s Breast Oncology Center, ESMO24,
Source: oncodaily.comCategories: General Medicine News, Hem/OncsTweet-
RT @oncodaily: ESMO24 symposium on the management of oligoprogressive disease - @DFCI_BreastOnc @nlinmd @myESMO https://t.co/XslbMe6xyV…
-
-
Mashup Score: 1Is adjuvant ribociclib ready for prime time? - OncoDaily - 2 month(s) ago
Is adjuvant ribociclib ready for prime time? / A. Natarajan, Annals of Oncology, cancer, ESMO24, OncoDaily, Oncology, Paolo Tarantino, Ribociclib,
Source: oncodaily.comCategories: General Medicine News, Hem/OncsTweet-
RT @oncodaily: Is adjuvant ribociclib ready for prime time? https://t.co/SU6McoGe5m @Annals_Oncology @DFCI_BreastOnc @stolaney1 @drsarah…
-
-
Mashup Score: 3522nd Annual School of Breast Oncology - 2 month(s) ago
November 7-9, 2024
Source: www.gotoper.comCategories: General Medicine News, Hem/OncsTweet-
Mark your calendars for PER’s School of Breast Oncology (SOBO), November 7-9! Register for FREE using my last name (TOLANEY) as a discount code! I always learn so much from this incredible course! https://t.co/RJcDpuktte #gotoPER #SOBO24
-
RT @oncodaily: Excited to kick off my first day at @DFCI_BreastOnc - @IlanaSchlam https://t.co/gA28BD8eo2 #Cancer #BreastOncology #OncoD…